The executive team at Coda Biotherapeutics has a long history of experience in the pharmaceutical and biotechnology industries. They have held positions on the board of directors for PhRMA and the Biotechnology Innovation Organization, and have served as the president and CEO of Orexigen Therapeutics. Most recently, they have been working as an officer, vice president, and general manager at Amgen. They hold degrees from the UCLA Anderson School of Management and the University of California, Davis.
View all